FDA Approves Telix's Brain Cancer Imaging Drug Pixclara
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2026 // -- Telix Pharmaceuticals Limited (ASX:TLX, NASDAQ:TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Pixclara® (floretyrosine F 18 or 18F-FE…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.